Catheter-related Bloodstream Infection
📧 Sign up to get email alerts when something new happens for Catheter-related Bloodstream Infection.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2024-12-19FDA Approved: DEFENCATH — Supplemental Application (CorMedix Inc.)
FDA approved a supplemental application for Defencath, a taurolidine and heparin catheter-lock solution from CorMedix Inc., indicating regul…
-
FDA approval · 2023-11-15FDA Approved: DEFENCATH — Original Application (CorMedix Inc.)
Defencath is a taurolidine and heparin catheter-lock solution that received FDA approval via CorMedix's original NDA.